st kitts eye study grand rounds, artes 2009)

Upload: paul-h-artes

Post on 30-May-2018

219 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)

    1/53

    The St Kitts Eye StudyGrand Rounds, January 2009

  • 8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)

    2/53

    Content

    Background of Project

    Screening

    Protocol of the St Kitts Eye Study

    What we have learned so far

    Where do we go from here

  • 8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)

    3/53

    Federation of St Kitts and Nevis

  • 8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)

    4/53

    St Kitts

    5 km

    168 sq.km

    35,000 inhabitants (2001 census)

  • 8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)

    5/53

    St Kitts and Halifax: Connections

  • 8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)

    6/53

    St Kitts and Halifax: Connections

    1991: Eye Centre of Joseph N FranceHospital established, with help from Halifax

    2001: first proposal for screening project

    2003: funds from industryAlcon, Allergan, Merck, Pfizer

    2005: it nearly happened2007: it nearly happened (again)

    2008: it really happened.

  • 8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)

    7/53

    Glaucoma and black ancestry

    St Lucia Study Ophthalmology (1989)

    Baltimore Eye Survey Am J Epidem (1991)

    The Barbados Eye Study Arch Ophth 1994)

    Survey of Ophthalmology (2003)

  • 8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)

    8/53

    Glaucoma and black ancestry

    prevalence 3 - 6 higher than in Caucasians

    earlier onset & more rapid progression

    5 larger prevalence of ocular hypertension (OHT)

    risk of progression from OHT to glaucoma

    rates of glaucoma-related blindness

    Survey of Ophthalmology (2003)

  • 8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)

    9/53

    Glaucoma in the Caribbean

    St Lucia Study Ophthalmology, 1989 Sep;96(9):1363-8

    1679 individuals, aged 30+ years

    VA, IOP, C/D ratio1/3 had supra-threshold screening fields on HFA

    positives underwent definitive exam, including threshold fields

    Prevalence of 8.8% in the 30+

    y population.

  • 8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)

    10/53

    What is Screening?

    Identify people whoprobablyhave a disease

    from those thatprobably do not.

  • 8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)

    11/53

    The condition sought should be an important health problem.

    There should be an accepted treatment.

    The natural history of the disease should be well understood.

    There should be a latent or early symptomatic stage.There should be a suitable and acceptable screening test.

    Facilities for diagnosis and treatment should be available.

    There should be an agreed policy on whom to treat as patients.

    Early treatment should be of benefit.

    The cost should be economically balanced.

    Case finding should be a continuing process.

    WHO criteria, after Wilson and Jungner (1968)

    Glaucoma screening: worthwhile?

  • 8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)

    12/53

    The condition sought should be an important health problem.

    There should be an accepted treatment.

    The natural history of the disease should be well understood.

    There should be a latent or early symptomatic stage.There should be a suitable and acceptable screening test.

    Facilities for diagnosis and treatment should be available.

    There should be an agreed policy on whom to treat as patients.

    Early treatment should be of benefit.

    The cost should be economically balanced.

    Case finding should be a continuing process.

    WHO criteria, after Wilson and Jungner (1968)

    Glaucoma screening: worthwhile?

  • 8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)

    13/53

    The condition sought should be an important health problem.

    There should be an accepted treatment.

    The natural history of the disease should be well understood.

    There should be a latent or early symptomatic stage.There should be a suitable and acceptable screening test.

    Facilities for diagnosis and treatment should be available.

    There should be an agreed policy on whom to treat as patients.

    Early treatment should be of benefit.

    The cost should be economically balanced.

    Case finding should be a continuing process.

    WHO criteria, after Wilson and Jungner (1968)

    Glaucoma screening: worthwhile?

  • 8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)

    14/53

    The condition sought should be an important health problem.

    There should be an accepted treatment.

    The natural history of the disease should be well understood.

    There should be a latent or early symptomatic stage.There should be a suitable and acceptable screening test.

    Facilities for diagnosis and treatment should be available.

    There should be an agreed policy on whom to treat as patients.

    Early treatment should be of benefit.

    The cost should be economically balanced.

    Case finding should be a continuing process.

    WHO criteria, after Wilson and Jungner (1968)

    Glaucoma screening: worthwhile?

  • 8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)

    15/53

    The condition sought should be an important health problem.

    There should be an accepted treatment.

    The natural history of the disease should be well understood.

    There should be a latent or early symptomatic stage.There should be a suitable and acceptable screening test.

    Facilities for diagnosis and treatment should be available.

    There should be an agreed policy on whom to treat as patients.

    Early treatment should be of benefit.

    The cost should be economically balanced.

    Case finding should be a continuing process.

    WHO criteria, after Wilson and Jungner (1968)

    Glaucoma screening: worthwhile?

  • 8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)

    16/53

    The condition sought should be an important health problem.

    There should be an accepted treatment.

    The natural history of the disease should be well understood.

    There should be a latent or early symptomatic stage.There should be a suitable and acceptable screening test.

    Facilities for diagnosis and treatment should be available.

    There should be an agreed policy on whom to treat as patients.

    Early treatment should be of benefit.

    The cost should be economically balanced.

    Case finding should be a continuing process.

    WHO criteria, after Wilson and Jungner (1968)

    Glaucoma screening: worthwhile?

  • 8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)

    17/53

    The condition sought should be an important health problem.

    There should be an accepted treatment.

    The natural history of the disease should be well understood.

    There should be a latent or early symptomatic stage.There should be a suitable and acceptable screening test.

    Facilities for diagnosis and treatment should be available.

    There should be an agreed policy on whom to treat as patients.

    Early treatment should be of benefit.

    The cost should be economically balanced.

    Case finding should be a continuing process.

    WHO criteria, after Wilson and Jungner (1968)

    Glaucoma screening: worthwhile?

  • 8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)

    18/53

    The condition sought should be an important health problem.

    There should be an accepted treatment.

    The natural history of the disease should be well understood.

    There should be a latent or early symptomatic stage.There should be a suitable and acceptable screening test.

    Facilities for diagnosis and treatment should be available.

    There should be an agreed policy on whom to treat as patients.

    Early treatment should be of benefit.

    The cost should be economically balanced.

    Case finding should be a continuing process.

    WHO criteria, after Wilson and Jungner (1968)

    Glaucoma screening: worthwhile?

  • 8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)

    19/53

    The condition sought should be an important health problem.

    There should be an accepted treatment.

    The natural history of the disease should be well understood.

    There should be a latent or early symptomatic stage.There should be a suitable and acceptable screening test.

    Facilities for diagnosis and treatment should be available.

    There should be an agreed policy on whom to treat as patients.

    Early treatment should be of benefit.

    The cost should be economically balanced.

    Case finding should be a continuing process.

    WHO criteria, after Wilson and Jungner (1968)

    Glaucoma screening: worthwhile?

  • 8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)

    20/53

    The condition sought should be an important health problem.

    There should be an accepted treatment.

    The natural history of the disease should be well understood.

    There should be a latent or early symptomatic stage.There should be a suitable and acceptable screening test.

    Facilities for diagnosis and treatment should be available.

    There should be an agreed policy on whom to treat as patients.

    Early treatment should be of benefit.

    The cost should be economically balanced.

    Case finding should be a continuing process.

    WHO criteria, after Wilson and Jungner (1968)

    Glaucoma screening: worthwhile?

  • 8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)

    21/53

    Glaucoma screening: worthwhile?

    S Hatt, R Wormald, J Burr

    Cochrane Database of Systematic Reviews 2008Screening for prevention of optic nerve damage

    due to chronic open angle glaucoma

    Main results

    As no trials were identified, no formal analysis

    was performed.

  • 8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)

    22/53

    Glaucoma screening: worthwhile?

    S Hatt, R Wormald, J Burr

    Cochrane Database of Systematic Reviews 2008Screening for prevention of optic nerve damagedue to chronic open angle glaucoma

    Main results

    As no trials were identified, no formal analysiswas performed.

  • 8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)

    23/53

    The Bottom Line

    Screeningcan be cost-effective in high-risk populations.

    Most economic evaluations compare tocurrent model of routine case-finding byoptometrists, which does not exist inCaribbean.

    Screening tests need very highspecificity to be workable.

  • 8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)

    24/53

    A good screening program

    simple, cheap, and accessible

    in peripheral health centres

    rely on local expertise (nurses, assistants)

    good sensitivity, and very high specificity

    false-positive rate

  • 8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)

    25/53

    Likelihood ratios

    sensitivity / (1 specificity)

  • 8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)

    26/53

    Likelihood ratios

    sensitivity / (1 specificity)

    Fagan Nomogram

  • 8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)

    27/53

    Likelihood ratios

    sensitivity / (1 specificity)

    Fagan Nomogram

  • 8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)

    28/53

    Likelihood ratios

    sensitivity / (1 specificity)

    Example:Moorfields Regression Analysis of HRT

    Sensitivity = 65%, Specificity = 95%

    Likelihood ratio = 0.65 / 0.05

    = 13

    Fagan Nomogram

  • 8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)

    29/53

    Brain Teaser

    Sensitivity = 50%

    Specificity = 95%

    Prevalence = 0.3%

  • 8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)

    30/53

    Brain Teaser

    Sensitivity = 50%

    Specificity = 95%

    Prevalence = 0.3%

    What is the probability that a patient with

    a positive test has the disease?

  • 8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)

    31/53

    Fagan Nomogram

  • 8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)

    32/53

    Fagan Nomogram

  • 8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)

    33/53

    Doctors with an average of 14 yrs experienceDoctors with an average of 14 yrs experience

    Answers ranged from 1% to 99%Answers ranged from 1% to 99%

    half of them estimating the probability as 50%half of them estimating the probability as 50%

    Gigerenzer,Gigerenzer,

    BMJ 2003;327:741-744BMJ 2003;327:741-744

    5%

  • 8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)

    34/53

    help establish a robust

    and effectivescreening

    program for St Kitts and

    wider Caribbean region

    Aim - St Kitts Eye Study

  • 8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)

    35/53

    Questions - St Kitts Eye Study

    Which tests provide high specificity and good

    sensitivity, in a Caribbean population?

    Which combination of tests provides the best

    trade-off between performance and effort?

    Can new technologies (eg HRT imaging)

    improve on the current standard of care?

  • 8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)

    36/53

    Objectives St Kitts Eye Study

    Examine a representative sample of 200

    individuals >50 yrs with screening tests as

    well as gold standard protocol.

    Establish combination of screening tests

    that provides specificity >98%.

    Establish criteria for referral to Eye Centre.

  • 8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)

    37/53

    random sample of St Kitts residents (n=370)

    drawn from Social Security list.

    invited to participate by letter from Ministry

    of Health

    completeprotocol of tests, including

    screening- and gold standard tests

    Design St Kitts Eye Study

  • 8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)

    38/53

    Visual Fields

    Frequency Doubling (Matrix) Perimetry

    Moorfields Motion Displacement Perimetry

    Suprathreshold (white-on-white) Perimetry(all screening tests on one eye only)

    Humphrey 24-2 Sita-Standard (both eyes)

  • 8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)

    39/53

  • 8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)

    40/53

    Tonometry

    EasyEye NCT (Keeler)

    Tonopen (Reichert)

    Goldmann Applanation Tonometry (GAT)

  • 8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)

    41/53

    Imaging

    Heidelberg Retina Tomograph (HRT2)

    Nidek AFC 230 Stereo Fundus Camera

    Dilated Fundus Examination (Volk 90D)

  • 8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)

    42/53

    Humphrey Matrix

    1% supra-threshold test

    Moorfields

    Motion Displacement

    Perimetry

    HFA 76 point 3-zone

    supra-threshold test

    HFA 24-2 SITA Std

    Threshold Visual Fields

    Keeler EasyEye

    Non-Contact Tonometry

    Tonopen

    Goldmann Applanation

    Tonometry

    Heidelberg Retina

    Tomograph 2

    Fundus Photography

    Gonioscopy

    Dilated exam of Anterior &

    Posterior Segments

    Clinical Decision &

    Referral (if appropriate)

    Consent, Interview,

    Visual Acuity SKES: Protocol

  • 8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)

    43/53

  • 8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)

    44/53

  • 8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)

    45/53

  • 8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)

    46/53

    Initial Findings

    Invited:

    373 individuals (169 women, 204 men)

    age range 50 87 yrs

    Participated:

    172 individuals (46%) of those invited44 individuals (opportunistic)

    208 (96%) completed entire program

  • 8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)

    47/53

    Initial Findings

    Prevalence of glaucoma

    18/172 = 10.5%

    8 previously unknown (44%)

    Prevalence of Ocular Hypertension

    15/172 = 9%12 previously unknown (80%)

  • 8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)

    48/53

    Initial Findings*

    Other conditions

    Pterygium: almost universal

    Significant cataract: ~25%

    Diabetic Retinopathy: ??

    AMD: very few

    * No formal analysis conducted as yet

  • 8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)

    49/53

    Initial Findings*

    Visual Fields

    High rate of unreliable results with thresholdperimetry.

    Moorfields Motion Displacement test easyto explain and well accepted.

    Matrix Frequency Doubling: high rate of

    abnormal test results

    * No formal analysis conducted as yet

  • 8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)

    50/53

    Initial Findings*

    Imaging

    Optic disc size distribution different from

    caucasians (larger number of large discs?)

    Fundus photography: significant number of

    nerve fibre layer defects as isolated finding.

    * No formal analysis conducted as yet

  • 8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)

    51/53

    Initial Findings*

    Tonometry

    Non-contact tonometry surprisingly well

    tolerated (but needs practice).

    Impression: NCT appears more accurate &

    precise compared to Tonopen.

    * No formal analysis conducted as yet

  • 8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)

    52/53

    Where do we go from here?

    Formal analysis of test performance,

    compared to gold standard of clinical

    examination.

    Report to Ministry of Health, St Kitts and

    Nevis, with suggested paradigm and cost

    estimates.

  • 8/14/2019 St Kitts Eye Study Grand Rounds, Artes 2009)

    53/53

    Younes Agoumi, Carol Beattie, Beulah &Terrela Byron, Balwantray Chauhan,Anthony Crouse, Stacey Durling, Marcelo